Indivior Pharmaceuticals (INDV) Treasury Shares (2022 - 2025)
Historic Treasury Shares for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $5.4 million.
- Indivior Pharmaceuticals' Treasury Shares rose 10439.67% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 10439.67%. This contributed to the annual value of $4.7 million for FY2024, which is 1146.77% down from last year.
- Latest data reveals that Indivior Pharmaceuticals reported Treasury Shares of $5.4 million as of Q3 2025, which was up 10439.67% from $5.5 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Treasury Shares registered a high of $5.9 million during Q4 2022, and its lowest value of -$122.0 million during Q3 2024.
- Over the past 4 years, Indivior Pharmaceuticals' median Treasury Shares value was -$11.0 million (recorded in 2023), while the average stood at -$23.2 million.
- As far as peak fluctuations go, Indivior Pharmaceuticals' Treasury Shares plummeted by 100909.09% in 2024, and later skyrocketed by 11238.61% in 2025.
- Indivior Pharmaceuticals' Treasury Shares (Quarter) stood at $5.9 million in 2022, then fell by 10.45% to $5.3 million in 2023, then fell by 11.47% to $4.7 million in 2024, then rose by 13.72% to $5.4 million in 2025.
- Its Treasury Shares was $5.4 million in Q3 2025, compared to $5.5 million in Q2 2025 and $4.5 million in Q1 2025.